UnitedHealth Group Incorporated $UNH Stake Lessened by PFG Advisors

PFG Advisors lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 52.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,556 shares of the healthcare conglomerate’s stock after selling 7,360 shares during the period. PFG Advisors’ holdings in UnitedHealth Group were worth $2,164,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. Capital Research Global Investors boosted its holdings in UnitedHealth Group by 126.9% in the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock worth $4,503,419,000 after purchasing an additional 7,293,009 shares during the period. Capital World Investors boosted its holdings in UnitedHealth Group by 18.8% in the third quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock worth $7,516,107,000 after purchasing an additional 3,439,182 shares during the period. Capital International Investors boosted its holdings in UnitedHealth Group by 11.1% in the third quarter. Capital International Investors now owns 17,499,949 shares of the healthcare conglomerate’s stock worth $6,042,710,000 after purchasing an additional 1,747,337 shares during the period. Lone Pine Capital LLC acquired a new position in UnitedHealth Group in the second quarter worth $528,273,000. Finally, Bessemer Group Inc. boosted its holdings in UnitedHealth Group by 152.3% in the third quarter. Bessemer Group Inc. now owns 1,823,871 shares of the healthcare conglomerate’s stock worth $629,783,000 after purchasing an additional 1,100,850 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $346.26 on Wednesday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $438.85. The firm’s 50-day simple moving average is $289.27 and its 200 day simple moving average is $316.84. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The stock has a market cap of $314.29 billion, a P/E ratio of 26.25, a P/E/G ratio of 1.49 and a beta of 0.40.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. During the same period in the previous year, the business earned $7.20 earnings per share. The company’s revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 17.66 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were given a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s payout ratio is 67.02%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 earnings and outlook: UNH beat EPS and revenue expectations for Q1 and raised FY‑2026 adjusted earnings guidance (>$18.25), which is the main catalyst for the rally — confirms improving margins and steadier cash generation. VIEW: UnitedHealth’s strong first quarter, forecast raise cheer Wall Street
• Positive Sentiment: Management and cost actions: Management emphasized cost discipline, leadership changes and a $1.5B AI investment to drive efficiency — investors view this as evidence the company can manage medical-cost headwinds and restore margins. UnitedHealth tops quarterly estimates, hikes profit outlook
• Positive Sentiment: Technology tailwind from Optum: Optum Real (AI-first claims/reimbursement platform) is scaling rapidly (hundreds of millions of transactions now, billions expected), which can lower claims friction and improve margins over time. UnitedHealth’s AI Is Rebuilding the Payment Layer of American Healthcare
• Neutral Sentiment: Analyst sentiment and positioning: Several firms have raised targets and reiterated buy ratings ahead of/after the print, supporting momentum but also reflecting expectations already baked into the rally. UnitedHealth Stock (UNH) Surges 7%+ on Q1 Earnings Beat – Here’s Why
• Negative Sentiment: Policy/program uncertainty: UnitedHealth warned of “challenges” around a Medicare obesity-drug pilot program, creating uncertainty about insurer participation and potential cost implications. This is a policy risk for future medical-costs and membership economics. UnitedHealth flags challenges in Medicare obesity drug pilot
• Negative Sentiment: Ongoing cost risks and legacy issues: Although results improved, commentators note medical-cost volatility and recent restructuring means execution risk remains (investors should watch upcoming guidance cadence and membership trends). UnitedHealth Group Reports Flat First-Quarter Earnings

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on UNH shares. Jefferies Financial Group boosted their price target on shares of UnitedHealth Group from $340.00 to $373.00 and gave the company a “buy” rating in a report on Monday. JPMorgan Chase & Co. reduced their price target on shares of UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a report on Monday, February 2nd. Mizuho reduced their price target on shares of UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a report on Thursday, February 5th. Raymond James Financial raised shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price target for the company in a report on Wednesday, April 1st. Finally, Evercore raised shares of UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $364.79.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.